In other countries
The same active substances on other registers, the same brand first.
- FaslodexCanada · 250 MG / 5 ML · Solution · Astrazeneca Canada INCSame brand
- FASLODEX 250 mg/5 ml SOLUCION INYECTABLESpain · 250 mg · solución inyectable en jeringa precargada · Astrazeneca AbSame brand
- Faslodex 250 MG Solucion InyectableSpain · 250 mg · solución inyectable en jeringa precargada · Astrazeneca Uk LimitedSame brand
- FaslodexEuropean Union · AstraZeneca ABSame brand
- FaslodexCroatiaSame brand
- FaslodexItaly · Soluzione iniettabile · Astrazeneca ABSame brand
- Faslodex 250 mg oplossing voor injectieNetherlands · Oplossing voor injectie · AstraZeneca ABSame brand
- FASLODEX 250 mgRomania · 250mg/5ml · sol. inj. · Astrazeneca ABSame brand
- FASLODEX 250mgRomania · 250mg/5ml · sol. inj. · Astrazeneca UK LTDSame brand
- Faslodex®Serbia · 250mg/5mL · rastvor za injekciju u napunjenom injekcionom špricu · PredstavniŠTvo Astrazeneca UK Limited BeogradSame brand
- Faslodex Solution For Injection 250 mg/5mlSingapore · 50 mg/ml · injection, solution · Astrazeneca Singapore Pte LTDSame brand
- FaslodexUnited States · 125MG/2.5ML, 250MG/5ML · solution · AstrazenecaSame brand
- Fulvestrant MylanEuropean Union · Mylan Pharmaceuticals LimitedSame form
- Fulvestrant MylanCroatiaSame form
- Carcivor 250 mg per 5 mlSaudi Arabia · Laboratories Farmalan SASame form
- Floristil 250 mg per 5 mlSaudi Arabia · Chia Tai Tianqing Pharmaceutical Group Co., Ltd (CTTQ)Same form
- Fulvestrant SPCSaudi Arabia · Dr. Reddy’s Laboratories Ltd. Formulation Unit VIISame form
- Full VArgentina · 250 MG / 5 ML · solución inyectable · Laboratorios Ima S.A.I.C.Same substance
- Fulvestrant InjectableCanada · 250 MG / 5 ML · Solution · Jamp Pharma CorporationSame substance
- Fulvestrant InjectionCanada · 250 MG / 5 ML · Solution · Sterimax INCSame substance
- Afultrant 250 MG Solucion Inyectable en Jeringa Precargada EfgSpain · 250 mg · solución inyectable · Bexal Farmaceutica S.A.Same substance
- Fulvestrant AptaPharma 250 mg otopina za injekciju u napunjenoj štrcaljkiCroatia · otopina za injekciju u napunjenoj štrcaljki · Apta Medica Internacional d.o.o., Likozarjeva ulica 6, Ljubljana, SlovenijaSame substance
- Fulvestrant AccordItaly · Soluzione iniettabile · Accord Healthcare, S.L.U.Same substance
- Fulvestrant AurobindoItaly · Soluzione iniettabile in siringa pre-riempita · Eugia Pharma (Malta) LimitedSame substance
- Fulvefar 250 mg oplossing voor injectie in een voorgevulde spuitNetherlands · Oplossing voor injectie · Laboratorios Farmalán, S.A.Same substance
- Fulvestrant Accord 250 mg oplossing voor injectie in voorgevulde spuitNetherlands · Oplossing voor injectie · Accord Healthcare B.V.Same substance
- Fulvestrant EVER PharmaNew Zealand · Inj 50 mg per ml, 5 ml prefilled syringeSame substance
- FALVAX 250mgRomania · 250mg · sol. inj. in seringa preumpluta · DR. Reddy'S Laboratories Romania SRLSame substance
- Faseligo®Serbia · 250mg/5mL · rastvor za injekciju u napunjenom injekcionom špricu · Zentiva Pharma D.O.O.Same substance
- Fulvestrant AccordSerbia · 250mg/5mL · rastvor za injekciju u napunjenom injekcionom špricu · Evropa Lek Pharma D.O.O. BeogradSame substance
- Eranfu Fulvestrant Solution for Injection in Pre-Filled Syringe 250MG / 5MLSingapore · 250mg / 5ml · injection, solution · Euro Asia Medico Pte. LTD.Same substance
- Femcord Solution for Injection 250 MG/5 MLSingapore · 250 mg/5 ml · injection, solution · Accord Healthcare Private LimitedSame substance
- FulvestrantUnited States · 250MG/5ML · solution · HBT Labs INCSame substance
- CligavyxUnited States · 250MG/5ML · solution · Avyxa HoldingsSame substance
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Anvisa, Brazil
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Fulvestrant
- Register
- Brazil (Anvisa)
- Status
- Authorised
- Status in the register
- Ativo
- Authorised
- 27 May 2003
- Registration
- 116180114
- Marketing authorisation holder
- Astrazeneca do Brasil Ltda
- Procedure
- Registered